Jared Fridley, MD
Neurological Surgery · Providence, RINPI 1669703633
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,113 of the $1,724 with a category attached, or 64.6%. 7 manufacturers reported payments, led by Globus Medical at 45.5% of the total. 2025 is the largest year on record at $939, more than ten times the $21 reported in 2021. That places this record below the midpoint for neurological surgery clinicians in RI, where the typical reported total is $2,683.
Across 18 payments — averaging $95.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$785
- Arthrex$361
- Core Surgical Group$294
- Johnson & Johnson$117
- Brainlab, Inc.$91
- Medtronic$58
- plus $19 from 1 others
Across 2 payments — averaging $1151.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Innovation Technologies Inc$2K
What the payments were for
- Travel & lodging$1,11365%
- Food & beverage$61135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 5 | $785 |
| Arthrex | 5 | $361 |
| Core Surgical Group | 3 | $294 |
| Johnson & Johnson | 1 | $117 |
| Brainlab, Inc. | 1 | $91 |
| Medtronic | 2 | $58 |
| Carlsmed, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,724 in reported general payments places this provider in the 30th percentile of 37 neurological surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 21 | $236 |
| Pregabalin | 18 | $222 |
| Methocarbamol | 13 | $194 |
| Gabapentin | 18 | $189 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Providence
- Albert TelfeianProvidence$148K
- Clark ChenProvidence$104K
- Tianyi NiuProvidence$72K
- Radmehr TorabiProvidence$45K
- Theresa WilliamsonProvidence$45K
- Ki-Eun ChangProvidence$40K
- Prakash SampathProvidence$37K
- Adetokunbo OyeleseProvidence$22K
- Raj ThakrarProvidence$21K
- Oluwaseun AkinduroProvidence$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.